Mail

ALKS - Alkermes plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

33.72

+1.18 (+3.63%)

As of 2:05PM EST. Market open.

Stock chart is not supported by your current browser

Previous Close	32.54
Open	32.37
Bid	33.90 x 1300
Ask	33.91 x 1100
Day's Range	32.35 - 34.35
52 Week Range	27.54 - 66.79
Volume	1,017,194
Avg. Volume	904,216

Market Cap	5.262B
Beta (3Y Monthly)	1.29
PE Ratio (TTM)	N/A
EPS (TTM)	-0.90
Earnings Date	Feb 12, 2019 - Feb 18, 2019
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	38.00

Trade prices are not sourced from all markets

All

News

Press Releases

ACCESSWIRE1 hour ago
DEADLINE ALERT -- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Alkermes plc, Inc. (ALKS) & Lead Plaintiff Deadline - February 25, 2019
NEW YORK, NY / ACCESSWIRE / February 19, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed Alkermes plc, Inc. ("Alkermes" or the "Company") ...
ACCESSWIRE1 hour ago
Immunomedics, Inc. (IMMU), Alkermes plc, Inc. (ALKS) and DXC Technology Company (DXC) Bronstein, Gewirtz & Grossman, LLC Class Action Update
NEW YORK, NY / ACCESSWIRE / February 19, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can ...
GlobeNewswire1 hour ago
Zhang Investor Law Announces the Filing of a Securities Class Action Lawsuit Against Alkermes Public Limited Company, Alerts of Feb. 25, 2019 Deadline – ALKS
Zhang Investor Law announces the filing of a class action lawsuit on behalf of shareholders who bought shares of Alkermes Public Limited Company (ALKS) from February 17, 2017 through November 1, 2018, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Alkermes investors under the federal securities laws. If you wish to serve as lead plaintiff, you must move the Court no later than February 25, 2019.
Thomson Reuters StreetEvents2 hours ago
Edited Transcript of ALKS earnings conference call or presentation 14-Feb-19 1:30pm GMT
Q4 2018 Alkermes Plc Earnings Call
GlobeNewswire2 hours ago
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of ARLO, ALKS and WRCDF, WCAGY
The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are encouraged to contact the firm regarding possible appointment as lead plaintiff and a preliminary estimate of their recoverable losses. If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court.
GlobeNewswire4 hours ago
CLASS ACTION UPDATE for IMMU, PRGO, ALKS and VALE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, Feb. 19, 2019 -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies..
Motley Fool4 hours ago
Alkermes Breaks $1 Billion
It took a few drugs to get there.
GlobeNewswire4 hours ago
Immunomedics, Inc. (IMMU), Alkermes plc, Inc. (ALKS) and DXC Technology Company (DXC) and YRC Worldwide Inc. (YRCW): Bronstein, Gewirtz & Grossman, LLC Class Action Update
NEW YORK, Feb. 19, 2019 -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following.
PR Newswire7 hours ago
Alkermes and Clovis Oncology Initiate Research Collaboration to Explore Combination Cancer Therapies
DUBLIN and BOULDER, Colo., Feb. 19, 2019 /PRNewswire/ -- Alkermes plc (ALKS) and Clovis Oncology, Inc. (CLVS) today announced that the companies have entered into a research collaboration to evaluate ALKS 4230, Alkermes' investigational engineered interleukin-2 (IL-2) variant immunotherapy, in combination with rucaparib, Clovis' marketed PARP inhibitor, and lucitanib, Clovis' investigational tyrosine kinase inhibitor. The collaboration will explore the potential anti-cancer effects of both treatment combinations in preclinical models across multiple tumor types.
GlobeNewswire23 hours ago
CLASS ACTION UPDATE for YRIV, ALKS, ASTE and GE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, Feb. 18, 2019 -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies..
ACCESSWIRE2 days ago
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alkermes plc. of Class Action Lawsuit and Upcoming Deadline - ALKS
NEW YORK, NY / ACCESSWIRE / February 17, 2019 / Pomerantz LLP announces that a class action lawsuit has been filed against Alkermes plc. (''Alkermes'' or the ''Company'') (ALKS) and certain of its officers and directors. The class action, filed in United States District Court, Eastern District of New York, and indexed under 19-cv-00624, is on behalf of a class consisting of all behalf of persons and/or entities who purchased or otherwise acquired Alkermes securities between February 17, 2017 through November 1, 2018, both dates inclusive (the ''Class Period''), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the ''Exchange Act'') and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
GlobeNewswire2 days ago
CLASS ACTION UPDATE for ALKS, MKL, MAXR and GSM: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, Feb. 17, 2019 -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies..
GlobeNewswire2 days ago
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of XRAY, AGN, ALKS and SVXY
The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are encouraged to contact the firm regarding possible appointment as lead plaintiff and a preliminary estimate of their recoverable losses. If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court.
GlobeNewswire2 days ago
CLASS ACTION UPDATE for YOGA, IMMU, ALKS and ASTE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, Feb. 17, 2019 -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies..
GuruFocus.com4 days ago
Alkermes PLC (ALKS) Files 10-K for the Fiscal Year Ended on December 31, 2018
Alkermes PLC is a fully integrated, biopharmaceutical company. Warning! GuruFocus has detected 2 Warning Signs with ALKS. For the last quarter Alkermes PLC reported a revenue of $315.8 million, compared with the revenue of $275.4 million during the same period a year ago.
GlobeNewswire4 days ago
ALKS FEBRUARY 25th DEADLINE: Rosen Law Firm Reminds Alkermes Public Limited Company Investors of Important Deadline in Securities Class Action – ALKS
NEW YORK, Feb. 15, 2019 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Alkermes Public Limited Company from February 17, 2017.
GlobeNewswire4 days ago
CLASS ACTION UPDATE for YRCW, XRAY and ALKS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided.
ACCESSWIRE4 days ago
DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Alkermes plc, Inc. (ALKS) & Lead Plaintiff Deadline - February 25, 2019
NEW YORK, NY / ACCESSWIRE / February 15, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed Alkermes plc, Inc. ("Alkermes" or the "Company") ...
GlobeNewswire4 days ago
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of GS, ARLO, ALKS and GSM
The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are encouraged to contact the firm regarding possible appointment as lead plaintiff and a preliminary estimate of their recoverable losses. If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court.
ACCESSWIRE4 days ago
INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Alkermes plc, Inc. (ALKS) & Lead Plaintiff Deadline - February 25, 2019
NEW YORK, NY / ACCESSWIRE / February 15, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed Alkermes plc, Inc.("Alkermes" or the "Company") ...
Zacks4 days ago
Alkermes (ALKS) Q4 Earnings & Revenues Surpass Estimates
Alkermes' (ALKS) earnings and sales exceed estimates in the fourth quarter of 2018.
ACCESSWIRE4 days ago
JA Solar Holdings Co. Ltd. (JASO), Immunomedics, Inc. (IMMU), Alkermes plc, Inc. (ALKS) Bronstein, Gewirtz & Grossman, LLC Class Action Update
NEW YORK, NY / ACCESSWIRE / February 15, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can ...
GlobeNewswire4 days ago
CLASS ACTION UPDATE for ARLO, XRAY, DXC and ALKS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided.
Motley Fool5 days ago
Alkermes Plc (ALKS) Q4 2018 Earnings Conference Call Transcript
ALKS earnings call for the period ending December 31, 2018.